Cell Therapy for CNS Trauma

被引:0
作者
K. K. Jain
机构
[1] Jain PharmaBiotech,
来源
Molecular Biotechnology | 2009年 / 42卷
关键词
Cell therapy; CNS trauma; Embryonic stem cells; Gene therapy; Neural stem cells; Neuroprotection; Neuroregeneration; Paraplegia; Personalized medicine; Spinal cord injury; Transplantation of cells; Traumatic brain injury;
D O I
暂无
中图分类号
学科分类号
摘要
Cell therapy plays an important role in multidisciplinary management of the two major forms of central nervous system (CNS) injury, traumatic brain injury and spinal cord injury, which are caused by external physical trauma. Cell therapy for CNS disorders involves the use of cells of neural or non-neural origin to replace, repair, or enhance the function of the damaged nervous system and is usually achieved by transplantation of the cells, which are isolated and may be modified, e.g., by genetic engineering, when it may be referred to as gene therapy. Because the adult brain cells have a limited capacity to migrate to and regenerate at sites of injury, the use of embryonic stem cells that can be differentiated into various cell types as well as the use of neural stem cells has been explored. Preclinical studies and clinical trials are reviewed. Advantages as well as limitations are discussed. Cell therapy is promising for the treatment of CNS injury because it targets multiple mechanisms in a sustained manner. It can provide repair and regeneration of damaged tissues as well as prolonged release of neuroprotective and other therapeutic substances.
引用
收藏
相关论文
共 93 条
  • [1] Jain KK(2008)Neuroprotection in Traumatic Brain Injury Drug Discovery Today 13 1082-1089
  • [2] Maegele M(2008)Stem cell-based cellular replacement strategies following traumatic brain injury (TBI) Minimally Invasive Therapy and Allied Technologies 17 119-131
  • [3] Schaefer U(2007)Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury Bone Marrow Transplantation 40 609-619
  • [4] Parr AM(2007)Differentiating Embryonic Neural Progenitor Cells Induce Blood–Brain Barrier Properties Journal of Neurochemistry 101 555-565
  • [5] Tator CH(2003)Genetically modified NT2 N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury Journal of Neuropathology and Experimental Neurology 62 368-380
  • [6] Keating A(2004)Ex Vivo Gene Therapy Using Targeted Engraftment of NGF Expressing Human NT2 N Neurons Attenuates Cognitive Deficits Following Traumatic Brain Injury in Mice Journal of Neurotrauma 21 1723-1736
  • [7] Weidenfeller C(2007)The potential application of gene therapy in the treatment of traumatic brain injury Neurosurgical Review 30 291-298
  • [8] Svendsen CN(2008)Cell therapies for traumatic brain injury Neurosurgical Focus 24 E18-813
  • [9] Shusta EV(2008)Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy Surgery 144 803-637
  • [10] Watson DJ(2007)Trauma-associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain Journal of Neurotrauma 24 625-383